Pastor, Fernando
Berraondo, Pedro
Etxeberria, Iñaki
Frederick, Josh
Sahin, Ugur
Gilboa, Eli
Melero, Ignacio
Article History
First Online: 7 September 2018
Competing interests
: I.M. declares financial and non-financial competing interests. I.M. reports receiving commercial research funding (grants) from Bristol-Myers Squibb (BMS) and Roche and serves as a consultant and/or advisory board member for Alligator, AstraZeneca, Bioncotech, BMS, F-STAR, Genmab, Incyte, Merck Serono, Molecular Partners, Roche–Genentech and Tusk. E.G. is founder of Sebastian Biopharma that licensed IP from the University of Miami to develop methods of inducing neoantigens. U.S. is CEO and co-founder of BioNTech, a company that develops mRNA therapeutics.